RUGGIERO, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 2.368
EU - Europa 1.613
AS - Asia 1.519
SA - Sud America 273
Continente sconosciuto - Info sul continente non disponibili 90
AF - Africa 49
OC - Oceania 2
Totale 5.914
Nazione #
US - Stati Uniti d'America 2.255
RU - Federazione Russa 766
SG - Singapore 676
IT - Italia 273
CN - Cina 246
VN - Vietnam 224
BR - Brasile 216
HK - Hong Kong 140
GB - Regno Unito 118
DE - Germania 93
FR - Francia 93
SE - Svezia 73
IE - Irlanda 70
KR - Corea 62
CA - Canada 53
ID - Indonesia 46
FI - Finlandia 38
BD - Bangladesh 30
AR - Argentina 25
IN - India 22
NL - Olanda 18
IQ - Iraq 14
JP - Giappone 14
MX - Messico 14
AT - Austria 13
CR - Costa Rica 11
LT - Lituania 11
ES - Italia 10
BE - Belgio 9
NG - Nigeria 9
VE - Venezuela 9
TG - Togo 8
TR - Turchia 8
ZA - Sudafrica 7
EC - Ecuador 6
SV - El Salvador 6
UA - Ucraina 6
JM - Giamaica 5
MA - Marocco 5
PK - Pakistan 5
UZ - Uzbekistan 5
BJ - Benin 4
CL - Cile 4
CO - Colombia 4
GT - Guatemala 4
HN - Honduras 4
PL - Polonia 4
SA - Arabia Saudita 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
CW - ???statistics.table.value.countryCode.CW??? 3
DZ - Algeria 3
GR - Grecia 3
JO - Giordania 3
PA - Panama 3
PH - Filippine 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BO - Bolivia 2
CY - Cipro 2
DK - Danimarca 2
GP - Guadalupe 2
IL - Israele 2
KG - Kirghizistan 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
PR - Porto Rico 2
RO - Romania 2
SN - Senegal 2
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BZ - Belize 1
CD - Congo 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MK - Macedonia 1
MN - Mongolia 1
MZ - Mozambico 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SC - Seychelles 1
TC - Turks e Caicos 1
UY - Uruguay 1
Totale 5.827
Città #
Dallas 434
Singapore 339
San Jose 282
Ashburn 251
Moscow 248
Chandler 213
Hong Kong 137
Council Bluffs 87
Verona 79
Dublin 68
Southend 68
The Dalles 60
Ho Chi Minh City 58
Beijing 54
Los Angeles 41
Jakarta 38
Dong Ket 36
Hanoi 36
Santa Clara 35
New York 33
Lawrence 32
Princeton 32
Sindelfingen 30
Rome 28
Lappeenranta 26
Milan 25
Columbus 23
Redondo Beach 22
Seoul 21
Jacksonville 20
Seattle 19
São Paulo 18
Buffalo 17
Nuremberg 14
Tokyo 14
Toronto 13
Wilmington 13
Montreal 12
Munich 12
Woodbridge 12
Ann Arbor 11
Frankfurt am Main 11
North Bergen 11
London 10
Abuja 9
Da Nang 9
Phoenix 9
San José 9
Brasília 8
Guangzhou 8
Lomé 8
Mexico City 8
Vienna 8
Atlanta 7
Chicago 7
McKinney 7
Norwalk 7
Redmond 7
Baghdad 6
Bangalore 6
Boardman 6
Brescia 6
Brooklyn 6
Brussels 6
Denver 6
Haiphong 6
Houston 6
Johannesburg 6
Orem 6
Rio de Janeiro 6
Salvador 6
Amsterdam 5
Buttapietra 5
Chennai 5
Dongguan 5
Helsinki 5
Madrid 5
North Hollywood 5
Ottawa 5
Regalbuto 5
San Francisco 5
Tashkent 5
Thái Nguyên 5
Tianjin 5
Belo Horizonte 4
Boston 4
Buenos Aires 4
Cotonou 4
Des Moines 4
Germering 4
Guarulhos 4
Limeira 4
Manchester 4
San Salvador 4
Shenyang 4
Tübingen 4
Walsall 4
Annandale 3
Biên Hòa 3
Cagliari 3
Totale 3.358
Nome #
MALAT1 Expression Is Deregulated in miR-34a Knockout Cell Lines 382
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes and CD4-independent gp120/41s. 268
HLA-C presence increases human immunodeficiency type 1 (HIV-1) infectivity by interacting with the envelope glycoprotein gp120/41 252
Advanced cellular models for rare disease study: exploring neural, muscle and skeletal organoids 195
Different decay of antibody response and VOC sensitivity in naïve and previously infected subjects at 15 weeks following vaccination with BNT162b2 156
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals 156
Children with perinatally acquired HIV exhibit distinct immune responses to 4CMenB vaccine 152
Increased prevalence of unstable HLA-C variants in HIV-1 rapid-progressor patients 148
Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy 138
Artificial Intelligence Applied to in vitro Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children 133
Blood CXCR3+ CD4 T cells are enriched in inducible replication competent HIV in aviremic antiretroviral therapy-treated individuals 133
Comparative analysis and generation of a robust HIV-1 DNA quantification assay 132
Factors associated with persistence of plasma HIV-1 RNA during long-term continuously suppressive firstline antiretroviral therapy 130
Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort) 130
During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR/DP/DQ 127
Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART 125
BNT162B2 mRNA COVID-19 vaccine in heart and lung transplanted young adults: is an alternative SARS-CoV-2 immune response surveillance needed? 123
Clinical, virological and immunological subphenotypes in a cohort of early treated HIV-infected children 122
Higher PIK3C2B gene expression of H1N1+ specific B-cells is associated with lower H1N1 immunogenicity after trivalent influenza vaccination in HIV infected children 121
Highly specific memory B cells generation after the 2nd dose of BNT162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal IgA 121
Pseudotyped viruses as a molecular tool to monitor humoral immune responses against SARS-CoV-2 via neutralization assay 120
HIV and SARS-CoV-2 co-infection: from population study evidence to in vitro studies 118
A quantitative method for the study of HIV-1 and Mycobacterium tuberculosis co-infection 114
Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring 113
Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workers 111
Immune signature in vaccinated versus non-vaccinated aged people with COVID-19 pneumonia 109
Generation of liposomes to study the effect of Mycobacterium Tuberculosis lipids on HIV-1 cis- and trans-infections 106
The immunology of Multisystem Inflammatory Syndrome in children with COVID-19 106
Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies 106
OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines 102
Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity 100
Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in Ghana 94
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies 94
Targeted protein degradation tools: overview and future perspectives 93
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection 92
The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: 'The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa' by Lemoine et al 92
The HCV envelope glycoprotein down-modulates NF-κB signalling and associates with stimulation of the host endoplasmic reticulum stress pathway 88
Measuring proviral HIV-1 DNA: hurdles and improvements to an assay monitoring integration events utilising human Alu repeat sequences 86
Subjects who developed SARS-CoV-2 specific IgM after vaccination show a longer humoral immunity and a lower frequency of infection 81
Measuring the success of HIV-1 cure strategies 81
Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology 79
Size of HIV-1 reservoir is associated with telomere shortening and immunosenescence in early-treated European children with perinatally acquired HIV-1 79
Utility of integrated HIV-1 DNA quantification in cure studies 77
CRISPR/Cas9 generation of HADHA KO PANC-1 cells to study the role of HADHA in pancreatic cancer stemness 68
Computational characterization of peptide binding stability to HLA-C allotypes and its association with HIV-1 infection progression and HIV-1 related neurocognitive impairment 63
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 51
Post-Translational Modifications in Respiratory Virus Infection: Recent Insights into the Development of In Vitro Models 47
CRISPR/Cas9-mediated generation of HADHA KO PANC-1 cells to study the role of HADHA in pancreatic cancer stemness 45
The absence of the human thioesterase ACOT8 negatively affects HIV-1 infectivity in vitro 43
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 41
Regulation of Tau Alternative Splicing: A Novel Role for the Ribonucleoprotein RBM20 25
RNA Splicing Dysregulation in Parkinson's Disease 14
High-Touch, High-Risk: An Exploratory Microbiome Analysis of Hospital Wheelchairs 13
Functional interplay between ACOT8 and Nef enhances HIV-1 infectivity and remodels the viral envelope 10
Burdock (Arctium lappa L.) Root Extract Induces Transcriptional Signatures Associated with Metal Homeostasis and Lipid Metabolism in Human Keratinocytes 9
Totale 5.914
Categoria #
all - tutte 23.788
article - articoli 20.917
book - libri 0
conference - conferenze 2.871
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.576


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022113 0 0 0 0 1 1 2 12 7 7 41 42
2022/2023600 42 63 55 96 46 130 10 40 82 9 18 9
2023/2024273 13 20 17 37 18 34 29 15 4 29 36 21
2024/2025999 44 52 35 193 25 41 86 59 161 64 65 174
2025/20262.988 189 140 461 396 630 175 268 161 237 210 41 80
2026/2027670 55 104 149 351 11 0 0 0 0 0 0 0
Totale 5.914